Svoronos Dawn 4
4 · Adverum Biotechnologies, Inc. · Filed Jun 20, 2025
Insider Transaction Report
Form 4
Graham Dawn
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-17+10,450→ 10,450 totalExercise: $2.32Exp: 2035-06-16→ Common Stock (10,450 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable on the earlier of June 17, 2026 or the 2026 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date.